Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-16

FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for desipramine hydrochloride from Heritage Pharmaceuticals (Avet) to support a marketed generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DESIPRAMINE HYDROCHLORIDE (Desipramine hydrochloride)

Snippet

SUPPL AP for DESIPRAMINE HYDROCHLORIDE (DESIPRAMINE HYDROCHLORIDE)